Silpa Deepa Kilaru

Silpa Kilaru practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Silpa Kilaru's NPI, 1033378013, was assigned on June 5, 2008. Silpa Kilaru graduated from Ohio State University College of Medicine in 2006. Silpa Kilaru holds Pennsylvania license MD444663.

Silpa Kilaru's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Silpa Kilaru's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Silpa Kilaru is also affiliated with Inova Fairfax Hospital. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Silpa Kilaru to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Silpa Kilaru practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Silpa Kilaru's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Silpa Kilaru is licensed in Pennsylvania.

CMS data shows 107 Medicare services from Silpa Kilaru across 1 procedure code in 2024, all of them office visits, for 31 Medicare patients. Medicare paid $10,964 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Silpa Kilaru in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 4.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Silpa Kilaru's median patient age at 62, with 52% women.

In 2024, Silpa Kilaru wrote 2,273 Medicare Part D claims for 55 patients. 90% of them were for generic drugs. CMS names the drug for 1,964 of them, across 46 drugs with 11 or more claims each, at $546,025 in total drug cost. In 2023, CMS named 1,522 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Silpa Kilaru for performance year 2024, reported as part of a group. Silpa Kilaru accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Silpa Kilaru from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. United Therapeutics Corporation paid the most, $266.

Silpa Kilaru graduated from Ohio State University College of Medicine in 2006.